Mark Holodniy, MD
Articles
May 19th 2014
Effect of Management Strategies and Clinical Status on Costs of Care for Advanced HIV
Paul G. Barnett, PhD Adam Chow, BA Vilija R. Joyce, MS Ahmed M. Bayoumi, MD, MSc Susan C. Griffin, MSc, BSc, PhD Huiying Sun, PhD Mark Holodniy, MD Sheldon T. Brown, MD D. William Cameron, MD Mark Sculpher, PhD Mike Youle, MB, ChB Aslam H. Anis, PhD Douglas K. Owens, MD, MS
Antiretroviral drugs have replaced hospitalization and other services as the most costly component of HIV care, except in patients with especially advanced HIV.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 19th 2024 | Updated: November 21st 2024
Institute for Value-Based Medicine®: Speakers Use AML Studies to Illustrate Effects of Disparities, Neighborhood Stress on Outcomes
